<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin HH</submitter><funding>National Health Research Institutes (NHRI)</funding><pagination>10537</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11615295</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>SPINT1, a membrane-anchored serine protease inhibitor, regulates cascades of pericellular proteolysis while its tissue-specific functions remain incompletely characterized. In this study, we generate Spint1-lacZ knock-in mice and observe Spint1 expression in embryonic pancreatic epithelium. Pancreas-specific Spint1 disruption significantly diminishes islet size and mass, causing glucose intolerance and downregulation of MAFA and insulin. Mechanistically, the serine protease HEPSIN interacts with SPINT1 in β cells, and Hepsin silencing counteracts the downregulation of Mafa and Ins1 caused by Spint1 depletion. Furthermore, we demonstrate a potential interaction between HEPSIN and GLP1R in β cells. Spint1 silencing or Hepsin overexpression reduces GLP1R-related cyclic AMP levels and Mafa exp</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Spint1 disruption in mouse pancreas leads to glucose intolerance and impaired insulin production involving HEPSIN/MAFA.</pubmed_title><pmcid>PMC11615295</pmcid><funding_grant_id>EX109-10725BI</funding_grant_id><pubmed_authors>Cheng MS</pubmed_authors><pubmed_authors>Lin HH</pubmed_authors><pubmed_authors>Huang SY</pubmed_authors><pubmed_authors>Lin HY</pubmed_authors><pubmed_authors>Huang HP</pubmed_authors><pubmed_authors>Chen TY</pubmed_authors><pubmed_authors>Chang YC</pubmed_authors><pubmed_authors>Ko CJ</pubmed_authors><pubmed_authors>Kan KW</pubmed_authors><pubmed_authors>Chen PH</pubmed_authors><pubmed_authors>Huang TC</pubmed_authors><pubmed_authors>Lee MS</pubmed_authors><pubmed_authors>Yu IS</pubmed_authors><pubmed_authors>Lin SW</pubmed_authors><pubmed_authors>Chang TJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spint1 disruption in mouse pancreas leads to glucose intolerance and impaired insulin production involving HEPSIN/MAFA.</name><description>SPINT1, a membrane-anchored serine protease inhibitor, regulates cascades of pericellular proteolysis while its tissue-specific functions remain incompletely characterized. In this study, we generate Spint1-lacZ knock-in mice and observe Spint1 expression in embryonic pancreatic epithelium. Pancreas-specific Spint1 disruption significantly diminishes islet size and mass, causing glucose intolerance and downregulation of MAFA and insulin. Mechanistically, the serine protease HEPSIN interacts with SPINT1 in β cells, and Hepsin silencing counteracts the downregulation of Mafa and Ins1 caused by Spint1 depletion. Furthermore, we demonstrate a potential interaction between HEPSIN and GLP1R in β cells. Spint1 silencing or Hepsin overexpression reduces GLP1R-related cyclic AMP levels and Mafa exp</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-18T12:52:34.712Z</modification><creation>2025-04-06T22:14:27.335Z</creation></dates><accession>S-EPMC11615295</accession><cross_references><pubmed>39627229</pubmed><doi>10.1038/s41467-024-54927-2</doi></cross_references></HashMap>